Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status

Published:2017-05-03 Issue:5 Volume:12 Page:e0176417
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mao Kai,Yang Yaping,Wu Wei,Liang Shi,Deng Heran,Liu Jieqiong^ORCID

Funder

the National Natural Science Foundation of China

Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology

the Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Lobular carcinoma in situ: A rare form of mammary cancer;FW Foote;Am J Pathol,1941

2. Trends in incidence and management of lobular carcinoma in situ: a population-based analysis;PR Portschy;Ann Surg Oncol,2013

3. Changing incidence of lobular carcinoma in situ of the breast;CI Li;Breast Cancer Res Treat,2002

4. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease;DL Page;Hum Pathol,1991

5. Atypical hyperplastic lesions of the female breast. A long-term follow-up study;DL Page;Cancer,1985

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypia detected during breast screening and subsequent development of cancer: observational analysis of the Sloane atypia prospective cohort in England;BMJ;2024-02-01

2. Breast screening atypia and subsequent development of cancer: protocol for an observational analysis of the Sloane database in England (Sloane atypia cohort study);BMJ Open;2022-01

3. Prognostic Significance of Lobular Carcinoma In-Situ (LCIS) Diagnosed Alongside Invasive Breast Cancer;Breast Cancer: Basic and Clinical Research;2022-01

4. Lesions of the breast with uncertain malignant potential;Tumors of female reproductive system;2021-09-20

5. Race, ethnicity and risk of second primary contralateral breast cancer in the United States;International Journal of Cancer;2021-02-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3